97 related articles for article (PubMed ID: 3792937)
21. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
22. Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent.
Seltzer V; Vogl S; Kaplan B
Gynecol Oncol; 1985 Jun; 21(2):167-76. PubMed ID: 3921437
[TBL] [Abstract][Full Text] [Related]
23. Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Ferrandina G; Fanfani F; Ludovisi M; Fagotti A; Carbone A; Zannoni G; Guerriero M; Petrillo M; Scambia G
Gynecol Oncol; 2008 Jan; 108(1):220-5. PubMed ID: 17976708
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
25. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
27. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
[TBL] [Abstract][Full Text] [Related]
28. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
29. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
30. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
31. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.
Malfetano J; Keys H; Kredentser D; Cunningham M; Kotlove D; Weiss L
Cancer; 1993 Jun; 71(11):3703-6. PubMed ID: 8387884
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node procedure followed by laparoscopic pelvic and paraaortic lymphadenectomy in women with IB2-II cervical cancer.
Lavoué V; Bats AS; Rouzier R; Coutant C; Barranger E; Daraï E
Ann Surg Oncol; 2007 Sep; 14(9):2654-61. PubMed ID: 17610015
[TBL] [Abstract][Full Text] [Related]
33. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S; Isohashi F; Yokoi T; Takemura M; Yoshino K; Shiki Y; Ito K; Enomoto T; Ogawa K; Kimura T
Gynecol Oncol; 2016 May; 141(2):240-246. PubMed ID: 26883141
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases.
Tattersall MH; Ramirez C; Coppleson M
Gynecol Oncol; 1992 Aug; 46(2):176-81. PubMed ID: 1500019
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy.
Wertheim MS; Hakes TB; Daghestani AN; Nori D; Smith DH; Lewis JL
J Clin Oncol; 1985 Jul; 3(7):912-6. PubMed ID: 2410573
[TBL] [Abstract][Full Text] [Related]
37. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
38. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
[TBL] [Abstract][Full Text] [Related]
39. Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer.
Kalaghchi B; Abdi R; Amouzegar-Hashemi F; Esmati E; Alikhasi A
Asian Pac J Cancer Prev; 2016; 17(S3):287-91. PubMed ID: 27165240
[TBL] [Abstract][Full Text] [Related]
40. Cis-diamminedichloroplatinum (II): second line induction chemotherapy in advanced ovarian adenocarcinoma.
Piver MS; Barlow JJ; Lele SB; Malfetano JH; McPhee ME
J Surg Oncol; 1983 Dec; 24(4):329-31. PubMed ID: 6418977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]